Navigation Links
Talyst Announces AutoSplit Contract Pharmacy at 340B Coalition
Date:6/29/2012

KIRKLAND, Wash., June 29, 2012 /PRNewswire/ -- Talyst, a leader in pharmacy automation, announces AutoSplit® Contract Pharmacy at the 16th  Annual 340B Coalition. The conference highlights will include sessions devoted to program integrity and audits, key considerations when developing contract pharmacy relationships, how the 340B program helps improve and expand patient care, and practical steps and policy solutions to address drug shortages.

AutoSplit Contract Pharmacy allows health systems to capture additional 340B savings from hospital scripts dispensed at retail pharmacies. The solution is an end-to-end managed service that gives covered entities the opportunity to capture increased 340B savings.

"Disproportionate Share Hospitals (DSH) can benefit from a 340B program," said Carla Corkern, Chief Executive Officer at Talyst. "Through their additional savings from Contract Pharmacy, the DSH can provide better and safer care to their patients."

Talyst will be exhibiting at the Coalition in booth #33. For more information on the conference, visit http://www.340bcoalition.org/conferences/2012_annual/index.cfm.

About Talyst

Talyst is a leader in pharmacy automation and engineers the safer pharmacy. Our solutions provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than 600 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. We offer a powerful software platform with a suite of hardware components to meet your specific needs. Follow us on Twitter @Talyst_Inc or visit us at, www.talyst.com.


'/>"/>
SOURCE Talyst
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Talyst Announces New Automated Medication Packager
2. KALO Announces Distribution Areas
3. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
4. Medivir Announces an Interferon-Free Phase II Combination Trial With TMC435 and daclatasvir to Commence Shortly
5. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
6. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
7. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
8. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
9. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
10. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
11. Detroit Metro Convention & Visitors Bureau announces launch of Medical Meetings Initiative; recruits top leaders to Advisory Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... YORK , Sept. 12, 2017   EcoVadis , the leading ... has published the first annual edition of its Global CSR Risk and ... companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 ... ... Index ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time ... already been receiving positive feedback from customers trying the product for the first time, ... Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare and ... that it will transition to using only Worksheet S-10 to distribute Disproportionate Share Hospital ... three live 60-minute complimentary webinars on October 17, 2017 at 2 P.M. ...
(Date:9/20/2017)... ... September 20, 2017 , ... Recognising that in today’s busy ... Greeny delivers positive results in just three weeks. Setting the groundwork for a ... Fitting seamlessly into hectic work and family schedules, participants can lose up to ...
(Date:9/20/2017)... ... , ... “Finn Mouseson”: follows the exciting story of a mouse as the ... out on a journey that will show that friends are to be gathered but ... author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s degree in Fine Arts ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “Psalms of Humidity”: ... peace of mind and move the readers one step closer to God. “Psalms of ... realized that his mistakes that have been made within his life are the very ...
Breaking Medicine News(10 mins):